about
Top-down, Bottom-up and Middle-out Strategies for Drug Cardiac Safety Assessment via Modeling and SimulationsRecent Advances in Development and Application of Physiologically-Based Pharmacokinetic (PBPK) Models: a Transition from Academic Curiosity to Regulatory AcceptanceThe Role of Interaction Model in Simulation of Drug Interactions and QT ProlongationProgress and prospects of reactive oxygen species in metal carcinogenesisChemoprotective epigenetic mechanisms in a colorectal cancer model: Modulation by n-3 PUFA in combination with fermentable fiberOxidative stress, epigenetics, and cancer stem cells in arsenic carcinogenesis and preventionMicroRNA Regulating Glutathione S-Transferase P1 in Prostate Cancer.The Epigenetic Impact of Cruciferous Vegetables on Cancer PreventionDNA Methylation and Flavonoids in Genitourinary Cancers.Manipulating miRNA Expression: A Novel Approach for Colon Cancer Prevention and ChemotherapyEpigenetic Regulation by Sulforaphane: Opportunities for Breast and Prostate Cancer Chemoprevention.Epigenetic Regulation of miRNAs and Breast Cancer Stem Cells.One-Carbon Metabolism and Colorectal Cancer: Potential Mechanisms of ChemopreventionCruciferous vegetables, isothiocyanates, and prevention of bladder cancer.Current Perspectives on Epigenetic Modifications by Dietary Chemopreventive and Herbal PhytochemicalsRegulation of miRNAs by agents targeting the tumor stem cell markers DCLK1, MSI1, LGR5, and BMI1.Metformin Treatment for the Prevention and/or Treatment of Breast/Mammary TumorigenesisTargeting the COX-2 Pathway to Improve Therapeutic Response in the Obese Breast Cancer Patient PopulationTargeting HER2 Positive Breast Cancer with Chemopreventive Agents.A Perspective on Prostate Carcinogenesis and Chemopreventionn-3 Polyunsaturated Fatty Acids and their Role in Cancer Chemoprevention."Curcumin, the King of Spices": Epigenetic Regulatory Mechanisms in the Prevention of Cancer, Neurological, and Inflammatory Diseases.MicroRNA-Specificity Protein (Sp) Transcription Factor Interactions and Significance in Carcinogenesis.Dietary Glucosinolates Sulforaphane, Phenethyl Isothiocyanate, Indole-3-Carbinol/3,3'-Diindolylmethane: Anti-Oxidative Stress/Inflammation, Nrf2, Epigenetics/Epigenomics and In Vivo Cancer Chemopreventive Efficacy.Resveratrol and MalignanciesRetinoid Chemoprevention: Who Can Benefit?Extracting the Benefit of Nexrutine® for Cancer Prevention.Broccoli-Derived Sulforaphane and Chemoprevention of Prostate Cancer: From Bench to Bedside.MicroRNAs: New players in cancer prevention targeting Nrf2, oxidative stress and inflammatory pathways.Cancer Chemoprevention with Korean Angelica: Active Compounds, Pharmacokinetics, and Human Translational Considerations.NSAIDs and Colorectal Cancer Control: Promise and ChallengesWhen Anti-Aging Studies Meet Cancer Chemoprevention: Can Anti-Aging Agent Kill Two Birds with One Blow?Oxidative stress under ambient and physiological oxygen tension in tissue culture.Natural Agents Used in Chemoprevention of Aerodigestive and GI CancersInterplay between Reactive oxygen Species and MicroRNAs in Cancer.Role of Nrf2 and Autophagy in Acute Lung InjuryOntology-based Vaccine and Drug Adverse Event Representation and Theory-guided Systematic Causal Network Analysis toward Integrative Pharmacovigilance ResearchQuantitative Systems Pharmacology: A Framework for Context.Advances in miRNA-Mediated Mucin Regulation.Mechanistic Role of MicroRNA in Cancer Chemoprevention by Nonsteroidal Anti-inflammatory Drugs.
P1433
Q26739743-E2939A73-CB83-4158-B09E-74160DAAF5E1Q26745824-C8DAF08B-A16A-4569-B5DD-A8B8C3B0717FQ28077218-B21D0424-9A3B-45AD-89A0-1C097BE069F6Q28388934-7193584A-DBD3-41B6-9D72-A262B2D257D2Q28392829-604AA568-2C32-4E4B-8727-F717117C4F3BQ28393227-0546D32B-F841-4A63-90D2-F1F693152F42Q35163033-A701864C-03AB-4E24-889B-761F97FDB2F6Q35163136-7FE985B1-2C28-4F16-9A9B-D334C7DAA65BQ35623184-6D9E343B-B63D-4BA9-BEFD-917D13BAA71EQ35647187-D8B0BE24-CEF6-414B-B228-1CC98734BA75Q35668617-05E43D0F-FA50-4428-83C2-5720073FBFABQ35673753-4FF6E153-924C-41B2-B071-5BC63DB1B921Q35867147-9C386BDF-1E7E-4225-ABC0-ADF41F20169DQ35934829-FC098C8E-E4C6-4D25-A76C-01839342B8DBQ36003900-B5307ED1-C34A-4A5D-A696-F1D3C2146DB7Q36037205-4E002249-7D95-416D-86BC-9183706139EEQ36078840-89B42F03-0EF6-42DD-85F0-BB73A3D554ADQ36114823-6FF27114-9718-40DE-82A2-86D44DEA2F85Q36114852-3BFD6EA9-C73E-4BF2-839F-ED552EE5DC6DQ36116269-F21F6BE2-AD71-4ADB-B28E-F379BCF567E2Q36131716-F8731EBA-D828-4E18-9655-8446B4C2021EQ36131769-5C249574-34F0-4F10-9C7E-D0E49D977DD9Q36131780-0434C1D2-8717-4654-8F6A-2CE7A694C9F3Q36131792-D94530A1-3964-40F8-BB2B-8A59BBC68AB9Q36165476-768EB812-2264-4510-BCDB-BD8092FE55CEQ36236984-C5B0BF80-513D-4D5A-95CE-358D613844F7Q36236997-B0398FD3-AEFD-4396-8D3A-D5CCF8975DBAQ36255185-D5A40CE5-0366-4F68-8342-A0925E0753EDQ36319102-FDAE5663-BBA4-4C0A-BFB1-F0430419AC56Q36326652-FFD2E588-CFDD-48E6-B72B-8AD3AE61F1FBQ36381490-F70A9303-A061-4CE3-8017-1F3AE9D36C8EQ36442945-8781891C-B514-413B-8D98-3F7FC74A3EFCQ36733395-65B50BF7-01AF-4B5A-B409-29BFA172DB00Q36843653-AF217D89-0808-4122-897D-91EB59A3E34DQ36973327-11D6E73D-EBDD-4EAB-8688-9A0EDA1B940AQ36998874-FA2C2304-A628-4999-BDF4-F597760DCC02Q37118671-B5A3828D-7F26-4510-8647-F4C6267A2D26Q37200950-69958D3D-52EB-4ECC-AF68-E95610AC8163Q37420793-03E68B21-32DA-4620-A255-195F53BFEC80Q38554955-14716BD7-2381-4AE9-9B87-284804064B74
P1433
description
journal
@en
revista científica
@es
wetenschappelijk tijdschrift van Springer Science+Business Media
@nl
wissenschaftliche Fachzeitschrift
@de
name
Current pharmacology reports
@ast
Current pharmacology reports
@en
Current pharmacology reports
@es
Current pharmacology reports
@nl
type
label
Current pharmacology reports
@ast
Current pharmacology reports
@en
Current pharmacology reports
@es
Current pharmacology reports
@nl
altLabel
Curr Pharmacol Rep
@en
prefLabel
Current pharmacology reports
@ast
Current pharmacology reports
@en
Current pharmacology reports
@es
Current pharmacology reports
@nl
P3181
P1055
P1156
21100793213
P1476
Current pharmacology reports
@en